#$%^&*AU2018100925A420180809.pdf#####Abstract The invention relates to pharmaceutical compositions comprising A9-tetrahydrocannabinol (THC), cannabidiol (CBD) and a terpene fraction obtained by extraction of a Cannabis plant, and their use in the treatment of anxiety and/or post-traumatic stress disorder (PTSD). 10431607_1 (GHMatters) P108940.AU